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During periods of intense activity such as phagocytosis,
macrophages are thought to derive most of their energy
from glucose metabolism under both aerobic and anaerobic
conditions. To determine whether fatty acids released from
lipoproteins by macrophage lipoprotein lipase (LPL) could
substitute for glucose as a source of energy for phagocytosis,
we cultured peritoneal macrophages from normal and LPL
knockout (LPL-KO) mice that had been rescued from neo-
natal demise by expression of human LPL via the muscle
creatine kinase promoter. Normal and LPL-KO macro-
phages were cultured in medium containing normal (5 mM)
or low (1 mM) glucose, and were tested for their capacity to
phagocytose IgG-opsonized sheep erythrocytes. LPL-KO
macrophages maintained in 1 and 5 mM glucose phagocy-
tosed 67 and 79% fewer IgG-opsonized erythrocytes, respec-
tively, than macrophages from normal mice. Addition of
VLDL to LPL-expressing macrophages maintained in 1 mM
glucose enhanced the macrophages’ phagocytosis of IgG-
opsonized erythrocytes, but did not stimulate phagocytosis
by LPL-KO macrophages. Inhibition of secreted LPL with a
monoclonal anti-LPL antibody or with tetrahydrolipstatin
blocked the ability of VLDL to enhance phagocytosis by
LPL-expressing macrophages maintained in 1 mM glucose.
Addition of oleic acid significantly enhanced phagocytosis
by both LPL-expressing and LPL-KO macrophages main-
tained in 1 mM glucose. Moreover, oleic acid stimulated pha-
gocytosis in cells cultured in non–glucose-containing me-
dium, and increased the intracellular stores of creatine
phosphate. Inhibition of oxidative phosphorylation, but
not of glycolysis, blocked the capacity of oleic acid to stimu-
late phagocytosis. Receptor-mediated endocytosis of acetyl
LDL by macrophages from LPL-expressing and LPL-KO
mice was similar whether the cells were maintained in 5 or 1
mM glucose, and was not augmented by VLDL. We postu-
late that fatty acids derived from macrophage LPL-cata-
lyzed hydrolysis of triglycerides and phospholipids provide
energy for macrophages in areas that have limited amounts


























Macrophages are long-lived motile phagocytes that play vital
roles in host defense against microorganisms, in removal of se-
nescent cells and matrix proteins, and in resorption of dam-
aged and necrotic tissues. Macrophages survive and function
under the metabolically unfavorable circumstances of ischemic
and avascular (e.g., abscesses) tissues, a trait which distin-
guishes them from fibroblasts, epithelial, and muscle cells. The
capacity of macrophages to function under adverse conditions
may be due in part to their ability to use many different sub-
strates to generate metabolic energy. While glucose is their fa-
vored fuel under most conditions, macrophages at rest in vitro
have been shown to generate ATP from glutamine, lactate,
and keto-acids to varying degrees (1–3), depending on their
state of differentiation (e.g., peritoneal vs. alveolar macro-
phages) (4, 5).
Fatty acids are another source of fuel (4, 6), but are the
least readily available of the circulating energy sources. Most
of the fatty acids in blood or other extracellular fluids are con-
tained within lipoproteins where they are linked covalently to
glycerol, and form triglycerides and phospholipids. There are
two ways in which macrophages could obtain fatty acids from
lipoproteins. One is to endocytose the lipoproteins. Endocy-
tosed lipoproteins are delivered to lysosomes where their pro-
teins and glycerides are hydrolyzed, thereby releasing fatty ac-
ids and other degradation products into the cytoplasm where
they are available for further metabolism. Macrophages, how-
ever, endocytose few large, triglyceride-rich lipoproteins un-
less they have been partially metabolized (7, 8). The second
pathway involves extracellular hydrolysis of glycerides in lipo-
proteins, which allows the uptake primarily of the released
free fatty acids (9), and is the major pathway responsible for
fatty acid assimilation by adipocytes and myocytes (10). This





Macrophages, unlike other phagocytic leukocytes (e.g.,
neutrophils, eosinophils, basophils), have evolved a method to
obtain fatty acids without ingestion of whole lipoproteins.
Macrophages secrete LPL (8, 9), the major enzyme responsi-
ble for extracellular release of fatty acids from triglyceride-rich
 
Baoyun Yin and John D. Loike contributed equally to this study.
Address correspondence to Ira J. Goldberg, M.D., Department of
Medicine, Columbia University, 630 West 168th Street, New York,
NY 10032. Phone: 212-305-3678; FAX: 212-305-5384; E-mail: IJG3@
columbia.edu
 
Received for publication 4 November 1996 and accepted in revised

































I-labeled oxidized LDL; KO, knockout; L0-MCK, LPL knockout
mice whose macrophages make no LPL; LPL, lipoprotein lipase;
MCK, muscle creatine kinase; RBC, red blood cells; RT, reverse tran-
scription; THL, tetrahydrolipstatin.
 





lipoproteins. LPL activity is increased when macrophages are
activated (11, 12), a time when energy requirements are also
increased. A role for this enzyme in macrophage physiology
other than lipoprotein and lipid uptake has been suggested
(for review see reference 13), but has not been tested. The
availability of mice with macrophages genetically incapable of
expressing LPL and of specific LPL inhibitors allowed us to
test whether fatty acids derived from LPL-mediated hydrolysis
of exogenously supplied lipoproteins fuel phagocytosis, an en-
ergy-dependent process generally thought to be fueled pri-
marily by glucose. Our studies show that they do, but only un-






Levak-Frank et al. (14) produced a transgenic mouse in
which human LPL, encoded by an LPL minigene driven by a muscle
creatine kinase (MCK) promoter, was expressed only in skeletal mus-
cle. LPL knockout (KO) mice (15) were crossed with these LPL
transgenic animals yielding mice whose macrophages make no LPL.
We term these L0-MCK mice, and their macrophages LPL-KO. Elic-
ited peritoneal macrophages were obtained from 4–6 mo-old L0-





Macrophages from both normal
and L0-MCK mice were obtained and cultured as described (16, 17).
In brief, macrophages were harvested by peritoneal lavage 4 d after
injection of 1.0 ml thioglycollate broth. Cells were washed with PBS
containing 1.0 mM Ca and 0.5 mM Mg and were plated in DMEM
containing 10% FBS (Life Technologies Inc., Grand Island, NY) or
FBS dialyzed against PBS (DFBS) (Life Technologies Inc.). Nonad-
herent cells were removed by washing with DMEM 2 h after plating.




 10% FBS. After 3–4 d in
culture, the cells were switched to DMEM containing the indicated




Normal glucose medium consisted of DMEM




 10% FBS or DFBS. Low glucose medium con-




 10% DFBS (16) with or without









 10 DFBS. In some experiments, macrophages were incu-
bated in medium containing 0.4 mM oleic acid (18) (Sigma Chemi-
cal Co., St. Louis, MO) in DMEM containing 10% DFBS and 2%
fatty acid–free BSA (Sigma Chemical Co.) or control media also con-
taining added BSA.
THP-1 cells, a human macrophage-like cell line, were incubated








C in RPMI (Life Technologies,










 M phorbol myristate acetate
(Sigma Chemical Co.) to induce LPL synthesis and secretion (19).
The cells then were incubated in fresh medium as follows: normal






















 10% FBS for 3 d. The medium was collected and as-
sayed immediately for LPL activity. LPL was assayed by a modifica-
tion of a method described previously (20). Chicken antibovine milk
LPL antiserum (made as described by Goers et al. [21] and which
cross-reacts with murine LPL) and mouse anti–human LPL mono-





Total cellular RNA was extracted from the same
macrophages used for LPL measurements (Trisolv solution; Biotecx
Laboratories, Houston, TX), according to the manufacturer’s instruc-








 cells in a 35-mm dish were lysed in 1 ml ice-
cold Trisolv. The Trisolv solution was extracted with 0.2 ml of chloro-
form, the aqueous phase was separated, and 0.5 ml of isopropanol




























 primer was from the untranslated region of human LPL’s first






















mouse LPL. RNA was reverse transcribed into cDNA (Gene Amp
RNA PCR kit; Perkin-Elmer Corp., Norwalk, CT). In brief, the re-




g total RNA from perito-
neal macrophages, and random hexamer primer were incubated at

















l of the cDNA mixture was amplified with the primers indicated us-
ing standard protocols (14, 15). For human LPL, the protocol in-












C for 2 min.









C for 3 min. Reaction products were resolved by gel




Cells were maintained under the culture conditions
indicated in Results for 48 h before phagocytosis assays, were washed




l PBS containing the in-




l of a 1%vol/vol suspension of
IgG-opsonized sheep erythrocytes (E[IgG]). Uningested red blood





PBS. The cells were then fixed in 2.5% glutaraldehyde, and the num-
ber of ingested RBCs per 100 macrophages was assayed using a
phase-contrast microscope. Phagocytosis index is the number of RBC
ingested per 100 cells (16, 17).






















 macrophages were cultured in each well of 12-well
plates for 48 h in the medium indicated. Cells then were washed in se-














AcLDL. To remove the noninternalized AcLDL, the cells were





min in DMEM containing 1 mM glucose, 0.3% BSA, and 100 U/ml of
heparin, and washed with PBS at room temperature. The cells were




l methanol to extract DiI from internalized
DiI-AcLDL. DiI in the cell extract was quantitated using a fluores-
cence plate reader (El Khoury, Silverstein and Loike, manuscript in
preparation).

















macrophages were maintained for 48 h in each well of 24-well plates
in the same medium used for uptake of DiI-AcLDL. The cells then
were washed with DMEM containing 1 mM glucose and 0.3% BSA,






























I-oxLDL, the cells were washed three times with
DMEM, 1 mM glucose, 0.3% BSA, and were incubated for 15 min in
the same medium with 100 U/ml heparin. The cells were washed with




l of 0.1 N NaOH. Aliquots of the




To assess cellular glucose uptake and retention





-glucose (2-DG; DuPont NEN, Boston, MA), a glucose an-
alog that is converted to 2-deoxyglucose 6 phosphate but not metabo-
lized further (17, 24). Macrophages cultured for 48 h on coverslips in




 10% FBS were washed in PBS, and were




l of DMEM, 1 mM glucose, 0.3%





















l 1% vol/vol of glutaraldehyde fixed
IgG-opsonized sheep erythrocytes (E[IgG]) (19). The coverslips




H]2-DG was assayed in a
scintillation spectrometer.
To assess the effect of low and no glucose in the medium on mac-
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rophage ATP and creatine phosphate (CrP) levels, macrophages
were plated on 35-mm dishes, maintained in medium containing 0, 1,




oleic acid for 24 h, washed three times with cold




l cold perchloric acid, and ATP and CrP




Absence of LPL and LPL mRNA in LPL-KO macrophages
from L0-MCK mice.
 
LPL-expressing and LPL-KO macro-
phages were incubated for 3 d in medium containing 5 mM
glucose and 10% FBS. The medium was harvested and as-
sayed for triglyceride lipolytic activity. Monoclonal anti–
human LPL IgG (22) and polyclonal chicken anti–bovine milk
LPL antibodies were used in the assay to confirm the absence





 10 times more lipolytic activity than





monoclonal anti–human LPL IgG did not inhibit the LPL ac-





small amount of LPL activity in the medium from LPL-KO
cells (data not shown). In contrast, polyclonal chicken anti-




 70% of the LPL activity in the me-




), but did not block
the small amount of triglyceride-hydrolyzing activity in the
medium of LPL-KO macrophages (not shown). We have not
investigated further the residual triglyceride lipase activity in
the medium from LPL-KO macrophages. These studies con-
firm that peritoneal macrophages from normal mice synthesize
and secrete LPL, while macrophages from LPL-KO mice do not.
To confirm further the lack of LPL expression by LPL-KO
macrophages, RNA was isolated from normal and LPL-KO
macrophages, and was probed for human and mouse LPL
mRNA by RT-PCR. Using the primers described in Methods,
the expected PCR product from mouse LPL mRNA should be
310 bp, and the one from human LPL mRNA 410 bp. As




, the 310-bp RT-PCR product characteristic
of mouse LPL mRNA was not found in RNA extracted from




), but was detected in RNA




) and from mouse epididy-




). A 410-bp RT-PCR product characteristic of
human LPL mRNA was detected in THP-1 cells, which ex-




), but not in RNA from normal








). Therefore, the LPL-KO cells contained no mouse LPL
mRNA, and the MCK promoter did not drive LPL expression
in macrophages.
 
Effects of glucose and VLDL on phagocytosis.
 
To test
whether the amount of glucose and the presence of VLDL
would affect phagocytosis, normal (LPL-expressing) and LPL-
KO macrophages were maintained for 2 d in medium contain-
ing 1 or 5 mM glucose with or without added VLDL. VLDL
approximately doubled the phagocytic index of normal mac-
rophages maintained in medium containing 1 mM glucose,




). In contrast, addition of VLDL
had no stimulatory effect on E(IgG) ingestion by LPL-KO




). Since the glucose-deficient
cells were cultured in DFBS, we assessed whether cells main-
tained in 5 mM glucose, 10% DFBS differed from cells grown
in FBS. They did not; in this experiment the cells in FBS had a




278, whereas those in DFBS had a












 0.34). Overall, these re-
sults suggest that fatty acids generated by LPL hydrolysis of
VLDL provide fuel for phagocytosis.
In contrast to the effects on phagocytosis found in cells
maintained in low glucose, the presence of LPL expression and
VLDL had relatively minor effects on the phagocytic index of
cells maintained in medium containing 5 mM glucose. The
higher glucose concentration increased the phagocytic index of
LPL-expressing macrophages almost threefold. LPL-KO mac-
Figure 1. LPL expression in peritoneal macrophages from control 
and MCK-rescued LPL KO mice. (A) Absence of LPL activity in cul-
ture medium from KO macrophages. Mouse peritoneal macrophages 
(2 3 106 cells/dish) were cultured in DMEM containing 5 mM glu-
cose 1 10% FBS for 3 d. The medium was removed and the cells 
were incubated for 4 h at 378C in 1 ml of DMEM containing 5 mM 
glucose and 0.5% BSA. To release membrane-bound LPL, 0.5 U/ml 
heparin was added to the medium 10 min before its collection. The 
amount of LPL in the medium was assayed with antibodies against 
mouse (anti-LPL) or human LPL (anti–human LPL). The bars repre-
sent the mean value6SD of three experiments expressed as percent 
control macrophage LPL activity (100% activity 5 0.13 mmol FFA/h/
mg cell protein). (B) Absence of LPL mRNA in LPL-KO macro-
phages as determined by RT-PCR. Total RNA was isolated from the 
cells, and RT-PCR was performed as described in Methods. For 
mouse LPL, the 310-bp fragment of the mouse LPL gene was not am-
plified in LPL-KO macrophages (lane 1), but was detected in normal 
macrophages (lane 2) and in normal mouse epididymal fat (lane 3). 
For human LPL, the predicted 410-bp product was found only in 
THP-1 macrophages expressing human LPL (lane 4), but not in nor-
mal (lane 5) or LPL-KO mouse macrophages (lane 6). 
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rophages had a more than fourfold increase in phagocytic in-
dex when incubated in 5 mM rather than in 1 mM glucose, and
under these conditions the LPL-KO macrophages phagocy-
tosed 85% as many E(IgG) as LPL-expressing macrophages.
In the presence of VLDL and 5 mM glucose, neither LPL-
expressing or LPL-KO macrophages had a significant increase
in phagocytosis of E(IgG). Glucose, therefore, potentiated
macrophage phagocytosis. VLDL had no effect on phagocyto-
sis in the presence of 5 mM glucose. Thus, VLDL augmented
phagocytosis only under glucose limiting conditions.
Effect of oleate on phagocytosis. To test the hypothesis that
fatty acids stimulate phagocytosis by cells maintained in low
glucose, we assessed E(IgG) ingestion by LPL-expressing and
LPL-KO macrophages maintained in low glucose medium
supplemented with oleic acid (0.4 mM), or with VLDL. Oleic
acid supplementation increased E(IgG) phagocytosis by LPL-
expressing macrophages 2–3.7-fold (Fig. 3 A), and by LPL-KO
macrophages 3.4-fold (Fig. 3 B). As shown in Fig. 2 and in Fig.
3 A, addition of VLDL increased E(IgG) phagocytosis by
LPL-expressing macrophages threefold, but was without effect
in LPL-KO macrophages (Fig. 3 B). The phagocytosis stimula-
tory effect of VLDL in LPL-expressing macrophages was in-
hibited z 50% by tetrahydrolipstatin (THL), an LPL inhibitor
(26). Complete inhibition of the VLDL effect was not ob-
served because the THL, a competitive inhibitor, may not be
completely effective in blocking LPL activity, or because LPL
continued to mediate uptake of some VLDL via nonenzymatic
processes (27, 28). As expected, THL had no effect on phago-
cytosis by LPL-KO macrophages (Fig. 3 B). Taken together,
these data further support the hypothesis that VLDL stimu-
lates E(IgG) uptake by LPL-expressing macrophages by pro-
viding an LPL-releasable source of fatty acids.
To test further whether oleate could augment phagocytosis
by glucose-deprived cells, we compared phagocytosis in cells
maintained for 48 h in 0 mM glucose6oleate. Under these con-
ditions, phagocytosis was stimulated markedly by oleic acid;
the phagocytic index was only 88651 without oleate, and
8656260 in oleic acid–containing medium (P 5 0.014). In ad-
dition, we assessed whether acute addition of oleic acid would
increase phagocytosis. To do this, cells were maintained for
48 h in 0 mM glucose, and the oleic acid was added during a
subsequent 1-h incubation in PBS–FBS. The E(IgG) were then
added, and phagocytosis was allowed to occur. The phagocytic
index was greater in the presence of oleic acid, and increased
Figure 2. Effects of VLDL on the phagocytosis of IgG-opsonized 
RBC by LPL-expressing (control) and LPL-KO macrophages. Mouse 
peritoneal macrophages were plated on coverslips in 24-well plates, 
and were cultured in DMEM containing 1 mM glucose 1 10% DFBS 
or DMEM containing 5 mM glucose 1 10% FBS with (1) or without 
(2) VLDL (100 mg/ml) for 48 h. Cells were then incubated in PBS 
containing 1 mM glucose and 1% vol/vol E(IgG) for 1 h at 378C. The 
numbers of RBC in 100 cells on each coverslip were then counted mi-
croscopically. The bars represent the mean value6SD of triplicates. 
White bars, knockout; striped bars, control.
Figure 3. Effects of oleic acid (OA) and THL on phagocytosis of 
IgG-opsonized RBC by macrophages. Mouse peritoneal macro-
phages from normal mice (A) or L0-MCK mice (B) were plated on 
coverslips and cultured in DMEM containing 1 mM glucose 1 10% 
FBS. 0.4 mM of OA or 100 mg/ml of VLDL was added as indicated. 
0.1 mM THL (Hoffman-La Roche, Basel, Switzerland), an LPL in-
hibitor, was added to the medium by appropriate dilution of a THL 
stock solution (24 mM) in dimethylsulfoxide. These conditions are 
designated VLDL 1 THL. The bars represent the mean value6SD of 
triplicate samples.
Downloaded from http://www.jci.org on January 12, 2016.   http://dx.doi.org/10.1172/JCI119576
Role of Macrophage LPL in Phagocytosis 653
almost to the level seen with the more chronic oleic acid,
816614; this increase over the oleic acid–deficient condition
was statistically significant at P 5 0.012. Therefore, as ex-
pected, the effects of oleate addition were even more dramatic
in cells that were totally glucose deficient.
Since oleic acid augmented the phagocytic index of mac-
rophages maintained in 1 mM glucose, we examined the oleate
effect in the presence of an inhibitor of glycolysis, NaF, and an
inhibitor of oxidative metabolism, azide. As expected (Table
I), the phagocytic index of cells treated with 0.25 mM NaF was
reduced by . 30%. When NaF was added to cells preincu-
bated for 2 d in oleic acid, the phagocytic index was nearly
twofold greater than that of cells maintained in the absence of
oleic acid. Oleic acid, however, was unable to compensate fully
for the inhibition of glycolysis on phagocytosis. Cells treated
with 1.0 mM NaN3 had a similar phagocytic index to cells
grown in 1 mM glucose alone. Oleic acid addition did not in-
crease the phagocytic index of NaN3-treated cells. Therefore,
inhibition of oxidative metabolism, but not glycolysis, blocked
the oleate stimulation of phagocytosis. These data are consis-
tent with the hypothesis that oleic acid is metabolized to pro-
vide energy for cells, thereby enhancing phagocytosis.
Effect of inhibition of LPL on E(IgG) phagocytosis by
THP-1 cells. To examine the role of LPL in human macro-
phages, we maintained THP-1 cells, a human macrophage-like
cell line, in medium containing 1 mM glucose with and without
VLDL. VLDL stimulated E(IgG) phagocytosis in THP-1 mac-
rophages maintained in 1 mM glucose about 1.5-fold (Fig. 4,
solid bars). The stimulatory effect of VLDL was completely
abolished by pretreatment of THP-1 cells with anti–human
LPL IgG (Fig. 4, open bars), an antibody that blocks the inter-
actions of LPL with VLDL (22). These results confirm that
LPL is essential for VLDL to stimulate phagocytosis of
E(IgG) in human macrophages. They provide additional evi-
dence that macrophages use fatty acids as an alternative fuel
source under conditions where glucose is limiting. It should be
noted that anti-LPL IgG also had a small inhibitory effect
(z 15%) on E(IgG) ingestion by THP-1 cells maintained in
medium lacking added VLDL. Whether the antibody blocked
LPL-catalyzed lipolysis of the small amount of lipoproteins in
FBS or had a minor inhibitory effect on the interaction of
E(IgG) with Fc receptors is unknown.
1 mM glucose did not affect macrophage receptor–mediated
endocytosis. To determine whether limiting glucose affects
other forms of macrophage endocytosis besides Fc receptor–
mediated phagocytosis, we examined receptor-mediated en-
docytosis of DiI-AcLDL, a particle whose uptake in macro-
phages is mediated by type A scavenger receptors (29, 30). In
contrast to phagocytosis of E(IgG), LPL-expressing and LPL-
KO macrophages internalized equal amounts of DiI-AcLDL
whether maintained in medium containing 5 or 1 mM glucose,
and in the presence or absence of VLDL (Fig. 5). Glucose-
deficient (1 mM) medium also did not reduce DiI-AcLDL up-
take by THP-1 cells (data not shown).
We also examined the effects of medium containing 1 mM
glucose with and without VLDL on receptor-mediated en-
docytosis of 125I-oxLDL by LPL-expressing and LPL-KO mac-
rophages. As with DiI-AcLDL (Fig. 5), lowering medium glu-
cose to 1 mM and addition of VLDL had no effect on 125I-ox
LDL uptake by normal or LPL-KO macrophages (data not
shown). Thus, receptor-mediated endocytosis, unlike Fc recep-
tor–mediated phagocytosis, is insensitive to limited availability
of glucose and fatty acids in the medium.
ATP and CrP content of macrophages maintained in glu-
cose-deficient medium with or without oleic acid. Because oleic
acid augmented phagocytosis (an energy-requiring process),
we assessed whether macrophages had a difference in intracel-
lular forms of stored energy when the cells were maintained in
media containing added fatty acid. Oleic acid addition led to
no significant changes in CrP and ATP in macrophages main-
Table I. Effects of Metabolic Inhibitors on Phagocytic Index
Medium Inhibitor Phagocytic index
5 None . 2000







Peritoneal macrophages from LPL-expressing mice (5 3 105/coverslip)
were cultured in DMEM containing 10% DFBS and 1 or 5 mM glucose
(5 mM) with or without added oleic acid for 48 h. The indicated meta-
bolic inhibitors (0.25 mM NaF or 1.0 mM NaN3) were added to the me-
dia, and 48 h later phagocytosis of E(IgG) was assessed during 1 h at
378C. Phagocytosis of E(IgG) was assessed as described in Methods.
The values given are the mean6SD of the number of E(IgG) per 100
cells. 5 5 DMEM containing 5 mM glucose; 1 5 DMEM containing 1
mM glucose. 1 signifies addition of 0.4 mM oleic acid.
Figure 4. Effect of anti–human LPL IgG on phagocytosis by human 
macrophages. THP-1 cells were cultured at 0.5 3 106 cells/coverslip in 
RPMI containing 10% FBS and 1.6 3 1027 M phorbal myristic ace-
tate for 48 h to promote their differentiation into macrophages. The 
cells then were incubated for an additional 48 h in RPMI containing 1 
mM glucose and 10% DFBS with (1) or without added VLDL, and 
with (white bar) or without (black bar) anti–human LPL monoclonal 
antibody. The cells were washed and incubated in PBS containing 1 
mM glucose and 1% vol/vol E(IgG) for 1 h at 378C. The number of 
RBC ingested per 100 THP-1 cells on each coverslip was then 
counted microscopically. Bars represent the mean value6SD of trip-
licate samples. Black bar, 2Ab; white bar, 1Ab.
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tained in 5 mM glucose (Fig. 6). In contrast, when the cells
were glucose-deprived, intracellular energy stores were greater
if oleic acid was included during the incubation. As expected,
this effect was seen most dramatically in the cells maintained
in 0 mM glucose. CrP doubled in these cells at 6 and 24 h (CrP
from 0.2260.07 nmol/mg protein in 0 mM glucose to 0.526
0.10 nmol/mg protein with oleate, P 5 0.028). Despite this re-
sult, CrP was still only half of that of cells grown in 5 mM
glucose, which averaged 1.0360.23 nmol/mg protein. These
changes in energy stores paralleled the stimulation of phagocy-
tosis under these conditions (see above) where oleic acid
markedly increased phagocytosis in glucose-deprived cells,
but did not restore it to the levels observed in 5 mM glucose.
Smaller increases in both ATP and CrP (25–36%) were found
when oleic acid was added to cells maintained in 1 mM glucose
(data not shown). Therefore, oleic acid increased the amounts
of intracellular high-energy phosphate stores of glucose-
deprived cells.
A second method used to assess whether oleic acid substi-
tuted for glucose in cellular metabolism was to determine glu-
cose consumption in control versus oleic acid–supplemented
cells. To do this, the residual amounts of glucose in the media
at the end of the 48-h incubations were assessed. Cells grown
in 1 mM glucose plus oleic consumed approximately one-third
as much glucose as did cells cultured with no oleic acid. The re-
sidual glucose at the end of the 48-h incubation was 0.2160.02
mM in media from cells cultured in 1 mM glucose DMEM, and
0.3560.07 mM in cells cultured in 1 mM glucose DMEM plus
oleic acid (P 5 0.012). In contrast, addition of oleic acid to
cells grown in 5 mM glucose media plus 10% DFBS led to no
differences in glucose consumption; the final glucose concen-
trations were 3.0960.24 in oleic acid–treated cells versus
3.3460.17 in cells receiving no fatty acid (P 5 0.11). Therefore,
addition of oleic acid spared glucose, but only under glucose-
limited conditions.
Phagocytosis, but not receptor-mediated endocytosis, stimu-
lates 2-DG uptake and accumulation. Fc receptor ligation stim-
ulates macrophage glucose uptake and metabolism (1). There
Figure 5. Effects of glucose and VLDL on endocytosis of AcLDL by 
control (LPL-expressing) and LPL-KO mouse macrophages. Mouse 
peritoneal macrophages were cultured on 12-well plates with 2 3 106 
cells/well for 48 h in DMEM containing 1 mM glucose 1 10% DFBS, 
or DMEM containing 5 mM glucose 1 10% FBS with or without 100 
mg/ml VLDL. Cells were then incubated for 2 h in 500 ml of serumless 
DMEM containing 1 mM glucose, 0.3% BSA, and 3.5 mg DiI-AcLDL. 
Membrane-bound AcLDL was released by incubating the cells in the 
same medium containing 100 U/ml heparin for 15 min. Internalized 
DiI was extracted with 200 ml methanol and quantitated by fluores-
cence. Striped bar, control; white bar, knockout.
Figure 6. Cellular energy stores in cells grown in 0 or 5 mM glucose 
with or without oleic acid. Peritoneal macrophages (2 3 106/35 mm 
dish) were cultured in DMEM containing 0 or 5 mM glucose 1 10% 
DFBS with or without oleic acid (0.4 mM) for up to 24 h, and ATP 
and CrP levels were measured as described in Methods at 0, 6, and 
24 h of incubation. The values represent the mean of duplicate wells 
with each value measured in triplicate. Control values (time 0) for 
ATP and CrP were 0.45 and 1.40 nmol/mg cell protein. Open square, 
0 mM; closed square, 0 mM 1 OA; open circle, 5 mM; closed circle, 5 
mM 1 OA.
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are no comparable data on effects of ligation of macrophage
scavenger receptors. Therefore, we compared the effects of Fc
receptor–mediated phagocytosis of E(IgG) and scavenger
receptor–mediated endocytosis of DiI-AcLDL on [3H]2-DG
uptake by LPL-expressing and LPL-KO macrophages main-
tained in media containing 1 mM glucose. Receptor-mediated
endocytosis of DiI-AcLDL had no effect on macrophage up-
take and accumulation of [3H]2-DG, while phagocytosis of
E(IgG) stimulated macrophage [3H]2-DG uptake 2.7-fold
(Fig. 7). In these experiments, the sheep RBC were pretreated
with 2.5% glutaraldehyde to eliminate their capacity to inter-
nalize 2-DG. Previous studies (31) showed that glutaralde-
hyde-fixed RBC behave similarly to untreated RBC with re-
spect to ingestion via Fc receptors.
Discussion
This report provides the first evidence that fatty acids fuel
phagocytosis by macrophages under conditions of relative glu-
cose deprivation, and that LPL produced by macrophages
plays an essential role in this process by releasing fatty acids
from extracellular lipoproteins. Several lines of evidence sup-
port these conclusions. First, LPL-expressing and LPL-KO
peritoneal macrophages maintained for 48 h under conditions
of relative glucose deficiency (1 mM glucose) did not phagocy-
tose as efficiently as the same macrophages maintained in glu-
cose-sufficient medium (5 mM glucose) (Fig. 2). Addition of
VLDL to the glucose-deficient medium enhanced E(IgG) phago-
cytosis by LPL-expressing, but not LPL-KO, macrophages.
Second, supplementation of glucose-deficient medium with
oleate stimulated phagocytosis by both LPL-expressing and
LPL-KO macrophages between 2- and 3.7-fold (Table I, Fig.
3). Third, the phagocytosis-promoting effect of VLDL on
LPL-expressing macrophages was abolished by anti-LPL anti-
bodies (Fig. 4) and by the LPL inhibitor THL (Fig. 3). Fourth,
the capacity of oleate to stimulate phagocytosis by macro-
phages maintained in 1 mM glucose was abolished by an inhib-
itor of oxidative phosphorylation (NaN3) but not by an inhibi-
tor of glycolysis (NaF, Table I). Fifth, studies performed using
cells grown in 0 mM glucose showed that oleic acid acutely
stimulates phagocytosis and increases cellular CrP.
Newsholme and colleagues (2, 32) found that oxidation of
oleate accounts for between 22 and 38% of ATP generation by
resting thioglycollate-elicited mouse peritoneal macrophages.
This finding prompted them to suggest that long-chain fatty ac-
ids might be an important fuel source for macrophages, and
that LPL secreted by macrophages might generate these fatty
acids from lipoproteins in the extracellular milieu. The data re-
ported here provide strong support for their hypothesis.
The reason that we were able to observe the dependency of
macrophages on fatty acid–derived energy is that, unlike most
previous studies (1, 32), we maintained macrophages in hy-
poglycemic conditions. Unlike the studies by Speert and Gor-
don (4) that suggest that pseudomonas are not ingested in the
absence of glucose, we specifically examined the role of fatty
acid metabolism in IgG-dependent phagocytosis. Our results
are most relevant to macrophages that reside and function for
prolonged periods of time in tissue compartments where glu-
cose is limited.
Several other roles have been proposed for macrophage
LPL (13). First, it was proposed that macrophage LPL was re-
quired to catabolize large, triglyceride-rich lipoproteins, thereby
facilitating macrophage uptake of these partially degraded li-
poproteins and leading to lipid storage and foam cell develop-
ment (7–9). Second, studies by our group (27, 33, 34) and oth-
ers (35–37) have shown that LPL can function as an adhesion
molecule. Since LPL contains a heparin binding site and a
lipid-binding lid region (12), it can form a bridge between cells
and lipoproteins. By increasing lipoprotein association with
the cell surface, LPL can increase lipoprotein uptake by non-
enzymatic processes (34, 38). Moreover, LPL can serve as a
cell–cell adhesion molecule (39) because enzymatically active
LPL is a dimer and can simultaneously link proteoglycans on
two different cells, e.g., monocytes and endothelial cells. A
third function of macrophage LPL relates to the uptake of fat-
soluble vitamins by these cells. LPL has been shown to promote
cellular uptake of vitamins A and E (40, 41), thereby regulat-
ing the amount of these antioxidant and differentiation vita-
mins.
Our data show that fatty acids generated by the actions of
LPL provide an important fuel for macrophages. We showed
that LPL inhibitors partially (Fig. 3), or completely (Fig. 4),
blocked the capacity of VLDL to stimulate phagocytosis by
LPL-expressing macrophages. These inhibitors, however, had
no effect on the capacity of oleate to stimulate phagocytosis.
These findings indicate that secreted LPL must hydrolyze lipo-
proteins extracellularly for macrophages to obtain sufficient
fatty acids to promote phagocytosis. They strongly suggest that
macrophages do not endocytose sufficient lipoproteins from
the medium and/or hydrolyze sufficient lipoproteins intracellu-
larly to provide comparable amounts of fatty acids.
Energy requirements of macrophages are unique for this
type of white blood cell. Within the bloodstream and near the
vasculature, monocytes are in the presence of a sufficient
amount of glucose to maintain their cellular functions. Mono-
Figure 7. Effects of phagocytosis and endocytosis on 2-DG uptake by 
normal mouse macrophages. Mouse peritoneal macrophages were 
cultured on coverslips on 24-well plates at 106 cells/coverslip in 
DMEM containing 1 mM glucose and 10% FBS for 48 h. Cells were 
then incubated for 1 h in DMEM containing 1 mM glucose, 0.3% 
BSA, 0.1 mM of [3H]2-DG with or without 7 mg/ml of AcLDL or 1% 
vol/vol of glutaraldehyde-treated RBC. Cells were washed with PBS 
extensively, and the uptake of [3H]2-DG was quantitated. The bars 
represent the mean6SD of triplicate samples. The control value was 
1.2 nmol/h/mg protein.
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cytes do not express LPL; as monocytes differentiate into mac-
rophages, however, LPL is expressed (12, 42). The energy re-
quirements of macrophages change markedly when they are
activated. Moreover, as shown previously (16), macrophages
use more energy during phagocytosis. This effect would be
likely to occur while combating infections and removing debris
in damaged tissues. Macrophages are often functional and
most important in regions that have suboptimal blood perfu-
sion. These regions include abscess cavities, ischemic tissues,
and the alveolar space. Several LPL substrates from which
fatty acids could be generated are found in these sites. These
include lipoproteins, and the triglyceride and phospholipids
that are components of the membranes of cells and micro-
organisms.
The atherosclerotic plaque might also be an energy-limited
environment for the macrophage. Within a more advanced
plaque, these cells are often located in lipid-rich regions sur-
rounded by dense connective tissue. The exact conditions
found within the center of these lesions are difficult to know
for certain, and the extent to which glucose permeates these
zones is unknown. Macrophages within atherosclerotic lesions
express LPL (43, 44). We propose that within these lesions—
where macrophages proliferate, differentiate, and phagocytose
cell debris—LPL plays a major role in meeting the high energy
demands of the cells.
Fatty acids appear to be used differently in macrophages
than other cells such as adipocytes and myocytes. Adipocytes
use fatty acids to assemble and store triglycerides that in times
of need are hydrolyzed to produce fatty acids used for energy
by other cells (45, 46). In contrast, myocytes continually use
fatty acids as a primary energy source for contractile events.
Exercising skeletal muscle uses both glucose and fatty acids,
however, when glycogen stores are depleted almost all energy
is provided by fatty acid metabolism (47, 48). The macrophage,
possibly because of its peripatetic nature, has adopted a meta-
bolic system that contains features of both the adipocyte and
the myocyte. Although macrophages can store fatty acids as
triglyceride (49), extracellular fatty acids do not, per se, modu-
late the intracellular storage forms of high-energy phosphates
under normoglycemic conditions (Fig. 6). In our studies, hy-
poglycemia reduced macrophage energy stores. Macrophages
maintained in medium containing 1 mM glucose contained
about half as much CrP as macrophages maintained in me-
dium containing glucose at plasma concentrations (i.e., 5 mM
or 90 mg/100 ml); macrophages maintained in 0 mM glucose
had even less CrP. The addition of oleic acid stimulated phago-
cytosis by macrophages maintained in glucose-deficient me-
dium, and this stimulation, at least in the totally glucose-deprived
cells, paralleled the increase in CrP. This result suggests that
macrophages oxidize fatty acid stores to form high-energy
phosphagens, but only when required by a glucose-limited en-
vironment.
Several other cells and tissues may use fatty acids in a simi-
lar fashion to that observed in the macrophage. In situ hybrid-
ization studies have shown high concentrations of LPL mRNA
in hippocampal (50) and in spinal cord neurons (51). These
cells may use LPL-derived fatty acids for metabolic energy
since they function within the lower glucose concentrations in
the cerebral spinal fluid, a possibility that could be most im-
portant during development or after injury, times when neu-
ronal energy demands are greatest.
Another observation from our studies is that the energy re-
quirements for receptor-mediated endocytosis and phagocyto-
sis differ, and are consistent with a previous report that phago-
cytosis is more sensitive to inhibitors of ATP generation than
is receptor-mediated endocytosis (52). We measured receptor-
mediated endocytosis of modified lipoproteins that are inter-
nalized by different classes of scavenger receptors (23, 29, 30).
Maintenance of macrophages in 1 and 5 mM glucose did not
alter lipoprotein uptake by the cells. Also, addition of an alter-
native energy source, fatty acids, did not increase receptor-
mediated endocytosis. Further support for the hypothesis that
receptor-mediated endocytosis and phagocytosis differ in their
metabolic needs was obtained by assessing changes in glucose
uptake during these two processes. Phagocytosis, but not re-
ceptor-mediated endocytosis, augmented the uptake of 2-DG
by the cells. Thus, our data are consistent with the hypothesis
that receptor-mediated endocytosis and phagocytosis in mac-
rophages differ in their energy requirements.
Macrophages and myocytes express different isozymes of
creatine kinase. For example, murine peritoneal macrophages
express primarily the brain form of creatine kinase, and not
the muscle or heart forms (25). Transgenic mice used in these
studies were developed using a human LPL minigene driven
by a muscle-specific promoter of creatine kinase. Our results
show that human LPL was not expressed in macrophages from
these transgenic mice, consistent with our hypothesis (16) that
the MCK promoter is not expressed in the macrophage cell
lineage, and that different promoter elements are required for
creatine kinase expression in muscle and macrophages. Thus,
either a second gene or different promoter elements are re-
quired for creatine kinase expression in these macrophages.
Our studies of macrophage functions need to be correlated
with investigations of the role of macrophage LPL in vivo.
Since humans (53) that are LPL deficient do not have obvious
alterations in macrophage functions, it is likely that the fatty
acids are a secondary or backup source of energy. Since LPL-
deficient people have very high concentrations of circulating
triglyceride, however, it may be that sufficient non–LPL-medi-
ated triglyceride uptake by the cells occurs to provide the mac-
rophages with fatty acids derived from intracellular triglycer-
ide hydrolysis. Or, as likely occurs within the fat cells of these
people, cellular metabolism is maintained by more glucose up-
take.
Acknowledgments
The authors would like to thank Dr. David Severson for providing
the THL used in these experiments and Dr. Joseph El Khoury for as-
sisting with the endocytosis assays.
This study was supported by grants HL 21006 SCOR (B. Yin and
I.J. Goldberg) and HL54591 (P.H. Weinstock, J.L. Breslow, and I.J.
Goldberg) from the National Heart, Lung, and Blood Institute, by
grant AI20516 from the National Institute of Allergy and Infectious
Diseases, and a grant in aid from the American Heart Association,
New York Affiliate (J.D. Loike and S.C. Silverstein).
References
1. Oren, R., A.E. Farnham, K. Saito, E. Milofsky, and M.L. Karnovsky.
1963. Metabolic patterns in three types of phagocytizing cells. J. Cell Biol. 17:
487–501.
2. Newsholme, P., S. Gordon, and E.A. Newsholme. 1987. Rates of utiliza-
tion and fates of glucose, glutamine, pyruvate, fatty acids and ketone bodies by
mouse macrophages. Biochem. J. 242:631–636.
3. Loike, J.D., E. Kaback, S.C. Silverstein, and T.H. Steinberg. 1993. Lac-
Downloaded from http://www.jci.org on January 12, 2016.   http://dx.doi.org/10.1172/JCI119576
Role of Macrophage LPL in Phagocytosis 657
tate transport in macrophages. J. Immunol. 150:1951–1958.
4. Speert, D.P., and S. Gordon. 1992. Phagocytosis of unopsonized
Pseudomonas aeruginosa by murine macrophages is a two-step process requir-
ing glucose. J. Clin. Invest. 90:1085–1092.
5. Simon, L.M., S.G. Axline, B.R. Horn, and E.D. Robin. 1973. Adaptations
of energy metabolism in the cultivated macrophage. J. Exp. Med. 138:1413–
1425.
6. Newsholme, P., L.F. Costa Rosa, E.A. Newsholme, and R. Curi. 1996.
The importance of fuel metabolism to macrophage function. Cell Biochem.
Function. 14:1–10.
7. Lindqvist, P., J.L. Ostlund-Lindqvist, J.L. Witztum, D. Steinberg, and
J.A. Little. 1983. The role of lipoprotein lipase in the metabolism of triglycer-
ide-rich lipoproteins by macrophages. J. Biol. Chem. 258:9086–9092.
8. Huff, M.W., A.J. Evans, C.G. Sawyez, B.M. Wolfe, and P.J. Nestel. 1991.
Cholesterol accumulation in J774 macrophages induced by triglyceride-rich li-
poproteins. Comparison of very low density lipoprotein from subjects with type
III, IV, and V hyperlipoproteinemias. Arterioscler. Thromb. 11:221–233.
9. Evans, A.J., C.G. Sawyez, B.M. Wolfe, P.W. Connelly, G.F. Maguire, and
M.W. Huff. 1993. Evidence that cholesteryl ester and triglyceride accumulation
in J774 macrophages induced by very low density lipoprotein subfractions oc-
curs by different mechanisms. J. Lipid Res. 34:703–717.
10. Eckel, R.H. 1989. Lipoprotein lipase: a multifunctional enzyme relevant
to common metabolic diseases. N. Engl. J. Med. 320:1060–1068.
11. Domin, W.S., A. Chait, and S.S. Deeb. 1991. Transcriptional activation
of the lipoprotein lipase gene in macrophages by dexamethasone. Biochemistry.
30:2570–2574.
12. Khoo, J.C., E. Mahoney, and J.L. Witztum. 1981. Secretion of lipopro-
tein lipase by macrophages in culture. J. Biol. Chem. 256:7105–7108.
13. Goldberg, I.J. 1996. Lipoprotein lipase: central roles in lipoprotein me-
tabolism and atherosclerosis. J. Lipid Res. 37:693–707.
14. Levak-Frank, S., H. Radner, A. Walsh, R. Stollberger, G. Knipping, G.
Heofler, W. Sattler, P.H. Weinstock, J.L. Breslow, and R. Zechner. 1995. Mus-
cle-specific overexpression of lipoprotein lipase causes a severe myopathy char-
acterized by proliferation of mitochondria and peroxisomes in transgenic mice.
J. Clin. Invest. 96:976–986.
15. Weinstock, P.H., C.L. Bisgaier, K. Aalto-Setala, H. Radner, R. Ra-
makrishnon, S. Levak-Frank, A.D. Essenberg, R. Zechner, and J.L. Breslow.
1995. Severe hypertriglyceridemia, reduced high density lipoprotein and neona-
tal death in lipoprotein lipase knockout mice. J. Clin. Invest. 96:2555–2568.
16. Loike, J.D., V.F. Kozler, and S.C. Silverstein. 1979. Increased ATP and
creatine phosphate turnover in phagocytosing mouse peritoneal macrophages.
J. Biol. Chem. 254:9558–9564.
17. Michl, J., D.J. Ohlbaum, and S.C. Silverstein. 1976. 2-Deoxyglucose se-
lectively inhibits Fc and complement receptor-mediated phagocytosis in mouse
peritoneal macrophages. I. Description of the inhibitory effect. J. Exp. Med.
144:1465–1483.
18. Saxena, U., L.D. Witte, and I.J. Goldberg. 1989. Release of endothelial
cell lipoprotein lipase by plasma lipoproteins and free fatty acids. J. Biol. Chem.
264:4349–4355.
19. Auwerx, J.H., S. Deeb, J.D. Brunzell, G. Wolfbauer, and A. Chait. 1989.
Lipoprotein lipase gene expression in THP-1 cells. Biochemistry. 28:4563–4567.
20. Nilsson-Ehle, P., and M.C. Schotz. 1976. A stable, radioactive substrate
emulsion for assay of lipoprotein lipase. J. Lipid Res. 17:536–541.
21. Goers, J.W., M.E. Pedersen, P.A. Kern, J. Ong, and M.C. Schotz. 1987.
An enzyme-linked immunoassay for lipoprotein lipase. Analt. Biochem. 166:27–
35.
22. Goldberg, I., J. Paterniti, D. France, G. Martinelli, and J. Cornicelli.
1986. Production and use of a monoclonal antibody to human lipoprotein li-
pase. Biochim. Biophys. Acta. 878:168–176.
23. Sparrow, C.P., S. Parthasarathy, and D. Steinberg. 1989. A macrophage
receptor that recognizes oxidized low density lipoprotein but not acetylated low
density lipoprotein. J. Biol. Chem. 264:2599–2604.
24. Loike, J.D., L. Cao, J. Brett, S. Ogawa, S.C. Silverstein, and D. Stern.
1992. Hypoxia induces glucose transporter expression in endothelial cells. Am.
J. Physiol. 263:C326–C333.
25. Loike, J.D., V.F. Kozler, and S.C. Silverstein. 1984. Creatine kinase ex-
pression and creatine phosphate accumulation are developmentally regulated
during differentiation of mouse and human monocytes. J. Exp. Med. 159:746–
757.
26. Lookene, A., N. Skottova, and G. Olivecrona. 1994. Interaction of lipo-
protein lipase with the active site inhibitor tetrahydrolipstatin (Orlistat). Eur. J.
Biochem. 222:395–403.
27. Rumsey, S., J. Obunike, Y. Arad, R. Deckelbaum, and I. Goldberg.
1992. Lipoprotein lipase mediated uptake and degradation of low density lipo-
proteins by fibroblasts and macrophages. J. Clin. Invest. 90:1504–1512.
28. Chappell, D., G. Fry, M. Waknitz, L. Muhonen, M. Pladet, P. Iverius,
and D. Strickland. 1993. Lipoprotein lipase induces catabolism of normal tri-
glyceride-rich lipoproteins via the low density lipoprotein receptor-related pro-
tein/alpha 2-macroglobulin receptor in vitro. A process facilitated by cell-sur-
face proteoglycans. J. Biol. Chem. 268:14168–14175.
29. Krieger, M., and J. Herz. 1994. Structures and functions of multiligand
lipoprotein receptors: macrophage scavenger receptors and LDL receptor-
related protein (LRP). Annu. Rev. Biochem. 63:601–637.
30. El Khoury, J., C.A. Thomas, J.D. Loike, S.E. Hickman, L. Cao, and S.C.
Silverstein. 1994. Macrophages adhere to glucose-modified basement mem-
brane collagen IV via their scavenger receptors. J. Biol. Chem. 269:10197–
10200.
31. Loike, J.D., and S.C. Silverstein. 1983. A fluorescence quenching tech-
nique using trypan blue to differentiate between attached and ingested glutaral-
dehyde-fixed red blood cells in phagocytosing murine macrophages. J. Immu-
nol. Methods. 57:373–379.
32. Newsholme, P., R. Curi, S. Gordon, and E.A. Newsholme. 1986. Metab-
olism of glucose, glutamine, long-chain fatty acids and ketone bodies by murine
macrophages. Biochem. J. 239:121–125.
33. Saxena, U., M.G. Klein, T.M. Vanni, and I.J. Goldberg. 1992. Lipopro-
tein lipase increases low density lipoprotein (LDL) retention by subendothelial
cell matrix. J. Clin. Invest. 89:373–380.
34. Obunike, J., I. Edwards, S. Rumsey, L. Curtiss, W. Wagner, R. Deckel-
baum, and I. Goldberg. 1994. Cellular differences in lipoprotein lipase medi-
ated uptake of low density lipoproteins. J. Biol. Chem. 269:13129–13135.
35. Williams, K.J., G.M. Fless, K.A. Petrie, M.L. Snyder, R.W. Brocia, and
T.L. Swenson. 1992. Mechanisms by which lipoprotein lipase alters cellular me-
tabolism of lipoprotein(a), low density lipoprotein, and nascent lipoproteins.
Roles for low density lipoprotein receptors and heparan sulfate proteoglycans.
J. Biol. Chem. 267:13284–13292.
36. Eisenberg, S., E. Sehayek, T. Olivecrona, and I. Vlodavsky. 1992. Lipo-
protein lipase enhances the binding of lipoprotein to heparan sulfate on cell
surfaces and extracellular matrix. J. Clin. Invest. 90:2013–2021.
37. Mulder, M., P. Lombardi, H. Jansen, B.T. Van, R.R. Frants, and L.M.
Havekes. 1992. Heparan sulphate proteoglycans are involved in the lipoprotein
lipase-mediated enhancement of the cellular binding of very low density and
low density lipoproteins. Biochem. Biophys. Res. Commun. 185:582–587.
38. Beisiegel, U., W. Weber, and G. Bengtsson-Olivecrona. 1991. Lipopro-
tein lipase enhances the binding of chylomicrons to low density lipoprotein re-
ceptor-related protein. Proc. Natl. Acad. Sci. USA. 88:8342–8346.
39. Obunike, J.C., S. Pillarisetti, S. Paka, A. Sasaki, and I.J. Goldberg. 1997.
Lipoprotein lipase can function as a monocyte adhesion protein. Arterioscler.
Thromb. Vasc. Biol. In press.
40. Traber, M., T. Olivecrona, and H. Kayden. 1985. Bovine milk lipopro-
tein lipase transfers tocopherol to human fibroblasts during triglyceride hydrol-
ysis in vitro. J. Clin. Invest. 75:1729–1734.
41. Blaner, W.S., J.C. Obunike, S.B. Kurlandsky, M. al-Haideri, R. Piante-
dosi, R.J. Deckelbaum, and I.J. Goldberg. 1994. Lipoprotein lipase hydrolysis
of retinyl ester. Possible implications for retinoid uptake by cells. J. Biol. Chem.
269:16559–16565.
42. Chait, A., P.H. Iverius, and J.D. Brunzell. 1982. Lipoprotein lipase se-
cretion by human monocyte-derived macrophages. J. Clin. Invest. 69:490–493.
43. Yla-Herttuala, S., B. Lipton, M. Rosenfeld, I. Goldberg, D. Steinberg,
and J. Witztum. 1991. Macrophages and smooth muscle cells express lipopro-
tein lipase in human and rabbit atherosclerotic lesions. Proc. Natl. Acad. Sci.
USA. 88:10143–10147.
44. O’Brien, K., D. Gordon, S. Deeb, M. Ferguson, and A. Chait. 1992. Li-
poprotein lipase is synthesized by macrophage-derived foam cells in human
coronary atherosclerotic plaques. J. Clin. Invest. 89:1544–1550.
45. Arner, P. 1995. Impact of exercise on adipose tissue metabolism in hu-
mans. Int. J. Obes. Relat. Metab. Disord. 19 (Suppl. 4):18–21.
46. Coppack, S.W., M.D. Jensen, and J.M. Miles. 1994. In vivo regulation of
lipolysis in humans. J. Lipid Res. 35:177-193.
47. Saltin, B., and P.O. Astrand. 1993. Free fatty acids and exercise. Am. J.
Clin. Nutr. 57:757s–758s.
48. Coyle, E.F. 1995. Substrate utilization during exercise in active people.
Am. J. Clin. Nutr. 61:968s–979s.
49. Newsholme, P., and E.A. Newsholme. 1989. Rates of utilization of glu-
cose, glutamine, and oleate and formation of end-products by mouse peritoneal
macrophages in culture. Biochem. J. 261:211–218.
50. Goldberg, I.J., D.R. Soprano, M.L. Wyatt, T.M. Vanni, T.G. Kirchgess-
ner, and M.C. Schotz. 1989. Localization of lipoprotein lipase mRNA in rat tis-
sues. J. Lipid Res. 30:1569–1577.
51. Bessesen, D.H., C.L. Richards, J. Etienne, J.W. Goers, and R.H. Eckel.
1993. Spinal cord of the rat contains more lipoprotein lipase than other brain
regions. J. Lipid Res. 34:229–238.
52. Silverstein, S.C., R.M. Steinman, and Z.A. Cohn. 1977. Endocytosis.
Annu. Rev. Biochem. 46:669–722.
53. Brunzell, J. 1989. Familial lipoprotein lipase deficiency and other causes
of the chylomicronemia syndrome. In The Metabolic Basis of Inherited Dis-
ease. C.R. Scriber, A. Beaudet, W. Sly, and D. Valle, editors. McGraw Hill, Inc.
New York. 1165–1180.
Downloaded from http://www.jci.org on January 12, 2016.   http://dx.doi.org/10.1172/JCI119576
